articleThe LancetJul 1, 2007Closed access

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

DCDaniel CatovskySRS RichardsEMEstella MatutesDOD OscierMDMJS Dyer

Institute of Cancer Research · MRC Clinical Trials Unit at UCL · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

679
total citations
FWCI
35.59
Percentile
100%
References
34
Citations per year

Authors

19

Topics & keywords

Keywords
  • Fludarabine
  • Chlorambucil
  • Cyclophosphamide
  • Medicine
  • Internal medicine
  • Chronic lymphocytic leukemia
  • Chemotherapy
  • Oncology
No related works found for this paper.